{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:21:20Z","timestamp":1791753680143,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T00:00:00Z","timestamp":1345766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T00:00:00Z","timestamp":1345766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/cgt.2012.55","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T10:23:51Z","timestamp":1345803831000},"page":"667-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["A non-oncogenic HPV 16 E6\/E7 vaccine enhances treatment of HPV expressing tumors"],"prefix":"10.1038","volume":"19","author":[{"given":"B G","family":"Wieking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W C","family":"Spanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W T","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Gabitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Balcaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"J P","family":"Balint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F R","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,24]]},"reference":[{"key":"BFcgt201255_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/cncr.20998","volume":"103","author":"CH Shiboski","year":"2005","unstructured":"Shiboski CH, Schmidt BL, Jordan RC . Tongue and tonsil carcinoma: increasing trends in the US population ages 20\u201344 years. Cancer 2005; 103: 1843\u20131849.","journal-title":"Cancer"},{"key":"BFcgt201255_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/00016480601110170","volume":"127","author":"L Hammarstedt","year":"2007","unstructured":"Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007; 127: 988\u2013992.","journal-title":"Acta Otolaryngol"},{"key":"BFcgt201255_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ijc.11633","volume":"108","author":"EM Smith","year":"2004","unstructured":"Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766\u2013772.","journal-title":"Int J Cancer"},{"key":"BFcgt201255_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ijc.10960","volume":"104","author":"JM Ritchie","year":"2003","unstructured":"Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336\u2013344.","journal-title":"Int J Cancer"},{"issue":"7","key":"BFcgt201255_CR5","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/ijc.25474","volume":"128","author":"Serge J. Smeets","year":"2010","unstructured":"Smeets SJ, van der Plas M, Schaaij-Visser TB, van Veen EA, van Meerloo J, Braakhuis BJ et al. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways. Int J Cancer 128: 1596\u20131605.","journal-title":"International Journal of Cancer"},{"key":"BFcgt201255_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129\u20131136.","journal-title":"Cell"},{"key":"BFcgt201255_CR7","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.1073\/pnas.1435900100","volume":"100","author":"T Veldman","year":"2003","unstructured":"Veldman T, Liu X, Yuan H, Schlegel R . Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Nat Acad Sci USA 2003; 100: 8211\u20138216.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BFcgt201255_CR8","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1128\/JVI.02188-07","volume":"82","author":"WC Spanos","year":"2008","unstructured":"Spanos WC, Hoover A, Harris GF, Wu S, Strand GL, Anderson ME et al. The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth. J Virol 2008; 82: 2493\u20132500.","journal-title":"J Virol"},{"key":"BFcgt201255_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1093\/emboj\/18.9.2449","volume":"18","author":"A Brehm","year":"1999","unstructured":"Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ et al. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J 1999; 18: 2449\u20132458.","journal-title":"EMBO J"},{"key":"BFcgt201255_CR10","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K Munger","year":"2004","unstructured":"Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451\u201311460.","journal-title":"J Virol"},{"key":"BFcgt201255_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1874357901105010080","volume":"5","author":"CM D'Abramo","year":"2011","unstructured":"D'Abramo CM, Archambault J . Small molecule inhibitors of human papillomavirus protein - protein interactions. Open Virol J 2011; 5: 80\u201395.","journal-title":"Open Virol J"},{"key":"BFcgt201255_CR12","doi-asserted-by":"publisher","first-page":"s333","DOI":"10.2741\/1003","volume":"8","author":"JM Berry","year":"2003","unstructured":"Berry JM, Palefsky JM . A review of human papillomavirus vaccines: from basic science to clinical trials. Front Biosci 2003; 8: s333\u2013s345.","journal-title":"Front Biosci"},{"key":"BFcgt201255_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0194599811402944","volume":"145","author":"A Duray","year":"2011","unstructured":"Duray A, Descamps G, Bettonville M, Sirtaine N, Ernoux-Neufcoeur P, Guenin S et al. High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults. Otolaryngol Head Neck Surg 2011; 145: 230\u2013235.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"BFcgt201255_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"FUTUREIIStudyGroup","year":"2007","unstructured":"FUTUREIIStudyGroup Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915\u20131927.","journal-title":"N Engl J Med"},{"key":"BFcgt201255_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/archoto.2008.507","volume":"134","author":"DW Lee","year":"2008","unstructured":"Lee DW, Anderson ME, Wu S, Lee JH . Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer. Arch Otolaryngol 2008; 134: 1316\u20131323.","journal-title":"Arch Otolaryngol"},{"key":"BFcgt201255_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archoto.2009.159","volume":"135","author":"WC Spanos","year":"2009","unstructured":"Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol 2009; 135: 1137\u20131146.","journal-title":"Arch Otolaryngol"},{"key":"BFcgt201255_CR17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.72.2.926-933.1998","volume":"72","author":"A Amalfitano","year":"1998","unstructured":"Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, Chamberlain JS . Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol 1998; 72: 926\u2013933.","journal-title":"J Virol"},{"key":"BFcgt201255_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1128\/JVI.76.2.619-632.2002","volume":"76","author":"DX Nguyen","year":"2002","unstructured":"Nguyen DX, Westbrook TF, McCance DJ . Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol 2002; 76: 619\u2013632.","journal-title":"J Virol"},{"key":"BFcgt201255_CR19","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1016\/j.vaccine.2009.06.028","volume":"27","author":"ES Gabitzsch","year":"2009","unstructured":"Gabitzsch ES, Xu Y, Yoshida LH, Balint J, Amalfitano A, Jones FR . Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity. Vaccine 2009; 27: 6394\u20136398.","journal-title":"Vaccine"},{"key":"BFcgt201255_CR20","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder N, March KL, Trapnell BC . Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996; 70: 7498\u20137509.","journal-title":"J Virol"},{"key":"BFcgt201255_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/hed.21040","volume":"31","author":"R Williams","year":"2009","unstructured":"Williams R, Lee DW, Elzey BD, Anderson ME, Hostager BS, Lee JH . Preclinical models of HPV+ and HPV\u2212 HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck 2009; 31: 911\u2013918.","journal-title":"Head Neck"},{"key":"BFcgt201255_CR22","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011\u20132015.","journal-title":"Science"},{"key":"BFcgt201255_CR23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/nar\/25.13.2595","volume":"25","author":"NW Kim","year":"1997","unstructured":"Kim NW, Wu F . Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 2595\u20132597.","journal-title":"Nucleic Acids Res"},{"key":"BFcgt201255_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.imlet.2008.11.003","volume":"122","author":"ES Gabitzsch","year":"2009","unstructured":"Gabitzsch ES, Xu Y, Yoshida LH, Balint J, Gayle RB, Amalfitano A et al. A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses. Immunol Lett 2009; 122: 44\u201351.","journal-title":"Immunol Lett"},{"key":"BFcgt201255_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner M, Huibregtse JM, Vierstra RD, Howley PM . The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495\u2013505.","journal-title":"Cell"},{"key":"BFcgt201255_CR26","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1073\/pnas.94.13.6670","volume":"94","author":"SS Lee","year":"1997","unstructured":"Lee SS, Weiss RS, Javier RT . Binding of human virus oncoproteins to hDlg\/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Nat Acad Sci USA 1997; 94: 6670\u20136675.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BFcgt201255_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1023\/A:1023941703493","volume":"30","author":"M van Ham","year":"2003","unstructured":"van Ham M, Hendriks W . PDZ domains-glue and guide. Mol Biol Rep 2003; 30: 69\u201382.","journal-title":"Mol Biol Rep"},{"key":"BFcgt201255_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02723060","volume":"32","author":"DM Peters","year":"1996","unstructured":"Peters DM, Dowd N, Brandt C, Compton T . Human papilloma virus E6\/E7 genes can expand the lifespan of human corneal fibroblasts. In vitro Cell Dev Biol 1996; 32: 279\u2013284.","journal-title":"In vitro Cell Dev Biol"},{"key":"BFcgt201255_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archotol.133.5.495","volume":"133","author":"AC Hoover","year":"2007","unstructured":"Hoover AC, Spanos WC, Harris GF, Anderson ME, Klingelhutz AJ, Lee JH . The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium. Arch Otolaryngol 2007; 133: 495\u2013502.","journal-title":"Arch Otolaryngol"},{"key":"BFcgt201255_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/cgt.2010.82","volume":"18","author":"ES Gabitzsch","year":"2011","unstructured":"Gabitzsch ES, Xu Y, Balcaitis S, Balint JP, Jones FR . An Ad5[E1-, E2b-]-HER2\/neu vector induces immune responses and inhibits HER2\/neu expressing tumor progression in Ad5 immune mice. Cancer Gene Ther 2011; 18: 326\u2013335.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201255_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00262-010-0847-8","volume":"59","author":"ES Gabitzsch","year":"2010","unstructured":"Gabitzsch ES, Xu Y, Balint JP, Hartman ZC, Lyerly HK, Jones FR . Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA. Cancer Immunol Immunother 2010; 59: 1131\u20131135.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcgt201255_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1186\/1479-5876-1-14","volume":"1","author":"K Shafer-Weaver","year":"2003","unstructured":"Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T et al. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Transl Med 2003; 1: 1479\u20135876.","journal-title":"J Transl Med"},{"key":"BFcgt201255_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/cgt.2009.17","volume":"16","author":"T Osada","year":"2009","unstructured":"Osada T, Yang XY, Hartman ZC, Glass O, Hodges BL, Niedzwiecki D et al. Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity. Cancer Gene Ther 2009; 16: 673\u2013682.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201255_CR34","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1016\/j.vaccine.2011.08.038","volume":"29","author":"ES Gabitzsch","year":"2011","unstructured":"Gabitzsch ES, Xu Y, Balint JP, Balcaitis S, Sanders-Beer B, Jones FR . Induction and comparison of SIV immunity in Ad5 naive and Ad5 immune non-human primates using an AD5 [E1-, E2b-] based vaccine. Vaccine 2011; 29: 8101\u20138107.","journal-title":"Vaccine"},{"key":"BFcgt201255_CR35","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0140-6736(96)90674-1","volume":"347","author":"LK Borysiewicz","year":"1996","unstructured":"Borysiewicz LK, Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996; 347: 1523\u20131527.","journal-title":"Lancet"},{"key":"BFcgt201255_CR36","first-page":"5205","volume":"9","author":"PJ Baldwin","year":"2003","unstructured":"Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J et al. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 2003; 9: 5205\u20135213.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201255_CR37","first-page":"6032","volume":"63","author":"EJ Davidson","year":"2003","unstructured":"Davidson EJ, Boswell CM, Sehr P, Pawlita M, Tomlinson AE, McVey RJ et al. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16\/18 oncoproteins. Cancer Res 2003; 63: 6032\u20136041.","journal-title":"Cancer Res"},{"key":"BFcgt201255_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11373-006-9086-6","volume":"13","author":"CT Lin","year":"2006","unstructured":"Lin CT, Tsai YC, He L, Calizo R, Chou HH, Chang TC et al. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. J Biomed Sci 2006; 13: 481\u2013488.","journal-title":"J Biomed Sci"},{"key":"BFcgt201255_CR39","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1128\/JVI.78.16.8468-8476.2004","volume":"78","author":"S Peng","year":"2004","unstructured":"Peng S, Ji H, Trimble C, He L, Tsai YC, Yeatermeyer J et al. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. J Virol 2004; 78: 8468\u20138476.","journal-title":"J Virol"},{"key":"BFcgt201255_CR40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.vaccine.2008.11.099","volume":"27","author":"B Karanam","year":"2009","unstructured":"Karanam B, Gambhira R, Peng S, Jagu S, Kim DJ, Ketner GW et al. Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. Vaccine 2009; 27: 1040\u20131049.","journal-title":"Vaccine"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201255","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:45:14Z","timestamp":1647953114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,24]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFcgt201255"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2012.55","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,24]]},"assertion":[{"value":"12 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}